Cite
Data from Establishment of Patient-Derived Tumor Xenograft Models of Epithelial Ovarian Cancer for Preclinical Evaluation of Novel Therapeutics
MLA
Ronny Drapkin, et al. Data from Establishment of Patient-Derived Tumor Xenograft Models of Epithelial Ovarian Cancer for Preclinical Evaluation of Novel Therapeutics. Mar. 2023. EBSCOhost, https://doi.org/10.1158/1078-0432.c.6526395.
APA
Ronny Drapkin, Ursula A. Matulonis, Joan S. Brugge, David M. Livingston, Gordon B. Mills, Cloud Paweletz, Victor E. Velculescu, Paul T. Kirschmeier, Jessie English, Gerburg M. Wulf, Susan Fotheringham, Marian Novak, Huiying Piao, Eniko Papp, Vilmos Adleff, Mei Zheng, Colin C. Pritchard, Yiping Shen, Laura M. Selfors, … Joyce F. Liu. (2023). Data from Establishment of Patient-Derived Tumor Xenograft Models of Epithelial Ovarian Cancer for Preclinical Evaluation of Novel Therapeutics. https://doi.org/10.1158/1078-0432.c.6526395
Chicago
Ronny Drapkin, Ursula A. Matulonis, Joan S. Brugge, David M. Livingston, Gordon B. Mills, Cloud Paweletz, Victor E. Velculescu, et al. 2023. “Data from Establishment of Patient-Derived Tumor Xenograft Models of Epithelial Ovarian Cancer for Preclinical Evaluation of Novel Therapeutics,” March. doi:10.1158/1078-0432.c.6526395.